BATM Advanced Communications Ltd., together with its subsidiaries, engages in the development, production, and marketing of real-time technologies in Israel, the United States, and Europe. It operates through four segments: Cyber, Networking, Diagnostics, and Secondary. The Cyber segment provides integrated hardware and software solutions comprising cGate, a combined network encryption and security computing platform designed for governments, defense, and mission-critical networks; and cHSM, a hardware security module that provides security for sensitive data and applications by safeguarding and managing secrets, such as digital keys. The Networking segment is involved in the marketing, research, and development of data communication products, which includes Edgility, an open edge software platform that enables the deployment and life-cycle management of apps, network functions, and compute devices at the edge of the network; and a range of carrier grade demarcation and aggregation products for switching and routing applications, as well as embedded software for controlling and managing the infrastructure and devices. The segment offers its products for telecoms operators, managed service providers, and enterprises. The Diagnostics segment mainly engages in the development, sale, and distribution of in vitro diagnostics equipment, reagents, and laboratory consumables for medium-sized laboratories, hospitals, and blood banks. The Secondary segment distributes pharmaceutical and environmental monitoring products, and diagnostic tests; and produces pathogenic waste treatment and sterilization solutions for medical, agricultural, and pharmaceutical applications. The company also offers software services, such as training and technical support, laboratory service and maintenance; and construction contract services. BATM Advanced Communications Ltd. was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
| 93.4 | |
| 91.1 | |
| - | |
| 94.2 | |
| 91.1 | |
| 74.1-115 | |
| 422 M | |
| 437 M | |
| 123 M | |
| 0.67 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Clinical trials of BATM's new method for the rapid and comprehensive diagnosis of TB will be fully funded by the Stop TB Partnership HOD HASHARON, Israel, March 29, 2021/PRNewswire/ -- BATM (LSE: BVC...
Clinical trials of BATM's new method for the rapid and comprehensive diagnosis of TB will be fully funded by the Stop TB Partnership HOD HASHARON, Israel, March 29, 2021/PRNewswire/ -- BATM (LSE: BVC...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
